Development of early progression independent of relapse activity significantly impacts on disability accumulation in patients with multiple sclerosis

被引:0
作者
Zarate, Maria Agustina [1 ]
Marrodan, Mariano [1 ]
Piedrabuena, Maria Agustina [1 ]
Fiol, Marcela Paula [1 ]
Ysrraelit, Maria Celica [1 ]
Correale, Jorge [1 ,2 ]
机构
[1] Fleni, Dept Neurol, Montaneses 2325, RA-1428 Buenos Aires, Argentina
[2] CONICET Univ Buenos Aires, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, Argentina
关键词
Multiple sclerosis; Progression independent of relapse activity; Disability accumulation; DIAGNOSTIC-CRITERIA; REVISIONS; SMOKING; TRIALS;
D O I
10.1016/j.msard.2025.106529
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Disability accumulation in multiple sclerosis (MS) is driven by relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA). Early PIRA (EP), occurring within five years of disease onset, has been proposed as a critical marker of poor prognosis. However, risk factors for EP remain poorly defined. Objective: To identify clinical and demographic factors associated with EP and assess its impact on long-term disability accumulation. Methods: This retrospective cohort study included 143 relapsing-remitting MS patients with disability progression (EDSS 4, 6, or 8) primarily due to PIRA. Patients were categorized as EP (PIRA within five years of onset) or late PIRA (LP, after five years). Cox regression and Kaplan-Meier survival analyses assessed risk factors and disability progression. Results: EP was identified in 39/77 (51 %) of PIRA patients. EP patients were older at diagnosis (38.6 vs. 34 years, p = 0.01), predominantly female (p = 0.02), and more likely to have spinal cord onset symptoms (p < 0.01). EP patients reached EDSS 4, 6, and 8 significantly faster than LP patients (p < 0.01). In multivariate analysis, spinal cord onset was the strongest predictor of EP (HR=2.1, 95 %CI=1.05-4.44, p = 0.03). Conclusions: EP occurs in half of PIRA patients and is associated with spinal cord onset and older age at diagnosis. These findings highlight the need for early identification and aggressive treatment to mitigate long-term disability. Further research is required to refine predictive models and optimize therapeutic strategies for high-risk patients.
引用
收藏
页数:6
相关论文
共 32 条
[1]   Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [J].
Cagol, Alessandro ;
Benkert, Pascal ;
Melie-Garcia, Lester ;
Schaedelin, Sabine A. ;
Leber, Selina ;
Tsagkas, Charidimos ;
Barakovic, Muhamed ;
Galbusera, Riccardo ;
Lu, Po-Jui ;
Weigel, Matthias ;
Ruberte, Esther ;
Radue, Ernst-Wilhelm ;
Yaldizli, Ozgur ;
Oechtering, Johanna ;
Lorscheider, Johannes ;
D'Souza, Marcus ;
Fischer-Barnicol, Bettina ;
Muller, Stefanie ;
Achtnichts, Lutz ;
Vehoff, Jochen ;
Disanto, Giulio ;
Findling, Oliver ;
Chan, Andrew ;
Salmen, Anke ;
Pot, Caroline ;
Bridel, Claire ;
Zecca, Chiara ;
Derfuss, Tobias ;
Lieb, Johanna M. ;
Remonda, Luca ;
Wagner, Franca ;
Vargas, Maria Isabel ;
Du Pasquier, Renaud A. ;
Lalive, Patrice H. ;
Pravata, Emanuele ;
Weber, Johannes ;
Cattin, Philippe C. ;
Absinta, Martina ;
Gobbi, Claudio ;
Leppert, David ;
Kappos, Ludwig ;
Kuhle, Jens ;
Granziera, Cristina .
NEUROLOGY, 2024, 102 (01)
[2]   Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study [J].
Chico-Garcia, Juan Luis ;
Amo, Raquel Sainz ;
Monreal, Enric ;
de la Maza, Susana Sainz ;
Jorge, Fernando Rodriguez ;
Masjuan, Jaime ;
Costa-Frossard, Lucienne ;
Villar, Luisa Maria .
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (10) :1239-+
[3]   Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) [J].
Chisari, Clara Grazia ;
Amato, Maria Pia ;
Di Sapio, Alessia ;
Foschi, Matteo ;
Iaffaldano, Pietro ;
Inglese, Matilde ;
Fermo, Salvatore Lo ;
Lugaresi, Alessandra ;
Lus, Giacomo ;
Mascoli, Nerina ;
Montepietra, Sara ;
Pesci, Ilaria ;
Quatrale, Rocco ;
Salemi, Giuseppe ;
Clerici, Valentina Torri ;
Totaro, Rocco ;
Valentino, Paola ;
Filippi, Massimo ;
Patti, Francesco .
JOURNAL OF NEUROLOGY, 2024, 271 (10) :6801-6810
[4]   Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis [J].
Ciccarelli, Olga ;
Barkhof, Frederik ;
Calabrese, Massimiliano ;
De Stefano, Nicola ;
Eshaghi, Arman ;
Filippi, Massimo ;
Gasperini, Claudio ;
Granziera, Cristina ;
Kappos, Ludwig ;
Rocca, Maria A. ;
Rovira, Alex ;
Sastre-Garriga, Jaume ;
Sormani, Maria Pia ;
Tur, Carmen ;
Toosy, Ahmed T. .
NEUROLOGY, 2024, 103 (01) :e209444
[5]   Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects [J].
Cohen, Jeffrey A. ;
Reingold, Stephen C. ;
Polman, Chris H. ;
Wolinsky, Jerry S. .
LANCET NEUROLOGY, 2012, 11 (05) :467-476
[6]   Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm [J].
Cree, Bruce A. C. ;
Mares, Jan ;
Hartung, Hans-Peter .
CURRENT OPINION IN NEUROLOGY, 2019, 32 (03) :365-377
[7]   Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation [J].
Dahlke, Frank ;
Arnold, Douglas L. ;
Aarden, Piet ;
Ganjgahi, Habib ;
Haring, Dieter A. ;
Cuklina, Jelena ;
Nichols, Thomas E. ;
Gardiner, Stephen ;
Bermel, Robert ;
Wiendl, Heinz .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (13) :2062-2076
[8]   Smouldering multiple sclerosis: the 'real MS' [J].
Giovannoni, Gavin ;
Popescu, Veronica ;
Wuerfel, Jens ;
Hellwig, Kerstin ;
Iacobeus, Ellen ;
Jensen, Michael B. ;
Garcia-Dominguez, Jose Manuel ;
Sousa, Livia ;
De Rossi, Nicola ;
Hupperts, Raymond ;
Fenu, Giuseppe ;
Bodini, Benedetta ;
Kuusisto, Hanna-Maija ;
Stankoff, Bruno ;
Lycke, Jan ;
Airas, Laura ;
Granziera, Cristina ;
Scalfari, Antonio .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
[9]   Time to Change the Current Clinical Classification of Multiple Sclerosis? [J].
Granziera, Cristina ;
Derfuss, Tobias ;
Kappos, Ludwig .
JAMA NEUROLOGY, 2023, 80 (02) :128-130
[10]   A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis [J].
Iaffaldano, Pietro ;
Lucisano, Giuseppe ;
Guerra, Tommaso ;
Paolicelli, Damiano ;
Portaccio, Emilio ;
Inglese, Matilde ;
Foschi, Matteo ;
Patti, Francesco ;
Granella, Franco ;
Romano, Silvia ;
Cavalla, Paola ;
De Luca, Giovanna ;
Gallo, Paolo ;
Bellantonio, Paolo ;
Gallo, Antonio ;
Montepietra, Sara ;
Di Sapio, Alessia ;
Vianello, Marika ;
Quatrale, Rocco ;
Spitaleri, Daniele ;
Clerici, Raffaella ;
Clerici, Valentina Torri ;
Cocco, Eleonora ;
Morra, Vincenzo Brescia ;
Marfia, Girolama Alessandra ;
Boccia, Vincenzo Daniele ;
Filippi, Massimo ;
Amato, Maria Pia ;
Trojano, Maria .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (08) :2008-2015